Skip to main content
Clinical Trials/NCT06063135
NCT06063135
Completed
Not Applicable

Effects of Physical Exercise Timing On Strength and Cardiometabolic Health

University of Basel1 site in 1 country152 target enrollmentNovember 21, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Physical Inactivity
Sponsor
University of Basel
Enrollment
152
Locations
1
Primary Endpoint
Maximum strength
Status
Completed
Last Updated
10 months ago

Overview

Brief Summary

Physical exercise is well known to improve human health. Current guidelines provide recommendations on the frequency, intensity, type and duration of exercise. However, they do not provide recommendations for the time of day, exercise should be performed. This is surprising considering that the influence of timing of behaviors such as sleep or nutrition as well as the impact of the circadian timing system on health are well documented. Further, there is evidence for diurnal variation in maximum performance which enables individuals to exercise with different intensities at different times of day, which in the long term might affect physical adaptations to exercise. Thus, this research study investigates if exercise timing impacts human health.

Registry
clinicaltrials.gov
Start Date
November 21, 2023
End Date
June 24, 2025
Last Updated
10 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Raphael Knaier

Researcher Group leader: Circadian Exercise

University of Basel

Eligibility Criteria

Inclusion Criteria

  • BMI 18.5 - 30 kg/m2

Exclusion Criteria

  • Structured resistance training within the last six months
  • Ongoing shift work
  • Irregular bedtime (\> 2 hours variation in habitual bed time)
  • Travels across more than two time zones within the last four weeks
  • Inability to follow the study procedures (e.g. due to language barriers, psychological disorders, dementia, etc.)
  • Known pregnancy or lactating women
  • Participation in any other clinical trial within the last four weeks
  • Medical condition that is a contra indicator for resistance training, endurance training, or exercising until maximum exhaustion including insufficiently controlled blood pressure (systolic \> 170 mmHg, diastolic \> 100 mmHg), ongoing cancer treatment, unstable angina pectoris, uncontrolled bradyarrhythmia or tachyarrhythmia, severe uncorrected valvular heart disease, clinically relevant acute infection, any form of musculoskeletal injury, orthopedic problems or decompensated cardiovascular disease
  • Insulin dependent diabetes
  • Participants using metformin

Outcomes

Primary Outcomes

Maximum strength

Time Frame: Pre-Intervention (i.e. 1 to 28 days before the first training session of the exercise intervention) and Post-Intervention (i.e. 1 to 28 days after the last training session of the exercise intervention)

Mean value of the maximum isometric strength assessed at four different times of the day with an isometric mid-thigh pull on a force plate.

Secondary Outcomes

  • Cardiorespiratory fitness(Pre-Intervention (i.e. 1 to 28 days before the first training session of the exercise intervention) and Post-Intervention (i.e. 1 to 28 days after the last training session of the exercise intervention))
  • Glucose control(Pre-Intervention (i.e. 1 to 28 days before the first training session of the exercise intervention) and Post-Intervention (i.e. 1 to 28 days after the last training session of the exercise intervention))
  • Body composition(Pre-Intervention (i.e. 1 to 28 days before the first training session of the exercise intervention) and Post-Intervention (i.e. 1 to 28 days after the last training session of the exercise intervention))

Study Sites (1)

Loading locations...

Similar Trials